Details of the Target
General Information of Target
| Target ID | LDTP05080 | |||||
|---|---|---|---|---|---|---|
| Target Name | Hemoglobin subunit beta (HBB) | |||||
| Gene Name | HBB | |||||
| Gene ID | 3043 | |||||
| Synonyms |
Hemoglobin subunit beta; Beta-globin; Hemoglobin beta chain) [Cleaved into: LVV-hemorphin-7; Spinorphin] |
|||||
| 3D Structure | ||||||
| Sequence |
MVHLTPEEKSAVTALWGKVNVDEVGGEALGRLLVVYPWTQRFFESFGDLSTPDAVMGNPK
VKAHGKKVLGAFSDGLAHLDNLKGTFATLSELHCDKLHVDPENFRLLGNVLVCVLAHHFG KEFTPPVQAAYQKVVAGVANALAHKYH |
|||||
| Target Type |
Clinical trial
|
|||||
| Target Bioclass |
Transporter and channel
|
|||||
| Family |
Globin family
|
|||||
| Function |
Involved in oxygen transport from the lung to the various peripheral tissues.; LVV-hemorphin-7 potentiates the activity of bradykinin, causing a decrease in blood pressure.; [Spinorphin]: Functions as an endogenous inhibitor of enkephalin-degrading enzymes such as DPP3, and as a selective antagonist of the P2RX3 receptor which is involved in pain signaling, these properties implicate it as a regulator of pain and inflammation.
|
|||||
| TTD ID | ||||||
| Uniprot ID | ||||||
| DrugMap ID | ||||||
| Ensemble ID | ||||||
| HGNC ID | ||||||
| ChEMBL ID | ||||||
Probe(s) Labeling This Target
ABPP Probe
| Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
|---|---|---|---|---|---|
|
IA-alkyne Probe Info |
![]() |
N.A. | LDD2242 | [1] | |
|
Acrolein Probe Info |
![]() |
H98(0.00); C94(0.00) | LDD0217 | [2] | |
|
TER-AC Probe Info |
![]() |
N.A. | LDD0426 | [3] | |
PAL-AfBPP Probe
| Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
|---|---|---|---|---|---|
|
FFF probe15 Probe Info |
![]() |
20.00 | LDD0478 | [4] | |
|
FFF probe2 Probe Info |
![]() |
20.00 | LDD0463 | [4] | |
Competitor(s) Related to This Target
The Interaction Atlas With This Target
The Protein(s) Related To This Target
Transporter and channel
| Protein name | Family | Uniprot ID | |||
|---|---|---|---|---|---|
| Hemoglobin subunit alpha (HBA1; HBA2) | Globin family | P69905 | |||
Other
| Protein name | Family | Uniprot ID | |||
|---|---|---|---|---|---|
| Hemoglobin subunit mu (HBM) | Globin family | Q6B0K9 | |||
| Hemoglobin subunit theta-1 (HBQ1) | Globin family | P09105 | |||
| Hemoglobin subunit zeta (HBZ) | Globin family | P02008 | |||
The Drug(s) Related To This Target
Approved
Phase 3
| Drug Name | Drug Type | External ID | |||
|---|---|---|---|---|---|
| Lentiglobin | . | D0C9LQ | |||
Phase 2
| Drug Name | Drug Type | External ID | |||
|---|---|---|---|---|---|
| Otl-300 | Gene therapy | D1RMS5 | |||
Investigative
References





